Updated:
GlobeStar Therapeutics Corp
GlobeStar Therapeutics Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001502152, and its reported...
Overview
GlobeStar Therapeutics Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001502152, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-01-19, it reported net income of USD -1,949,249 for the fiscal period ended 2023-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- GlobeStar Therapeutics Corp
- Former names in filing history
- AngioSoma, Inc. (2016-06-22 to 2021-05-21); First Titan Corp. (2010-11-03 to 2016-06-16)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Richland, WA, United States
- Incorporated in
- WY
- Fiscal year end
- September 30
- SEC CIK
- 0001502152
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | — | -$1.9M | — | — | -$205,760 | |
| FY2022USD | — | -$1.5M | $9,915 | $6,365 | -$326,995 | |
| FY2021USD | — | -$9.8M | $5,960 | $5,960 | -$751,232 | |
| FY2020USD | $77 | -$541,731 | $89,912 | $81,442 | -$239,735 |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K CURRENT REPORT FOR 08-08-2024 | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT FOR 06-30-2024 | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT FOR 03-31-2024 | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT FOR 12-31-2023 | ||
| 10-K | FORM 10-K ANNUAL REPORT FOR 09-30-2023 | ||
| 8-K | FORM 8-K CURRENT REPORT FOR 09-26-2023 | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT FOR 06-30-2023 | ||
| 8-K | FORM 8-K CURRENT REPORT FOR 06-27-2023 | ||
| 8-K | FORM 8-K CURRENT REPORT FOR 06-21-2023 | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT FOR 03-31-2023 | ||
| 8-K | FORM 8-K CURRENT REPORT FOR 04-04-2023 | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT FOR 12-31-2022 |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research GlobeStar Therapeutics Corp in Altss
Track this company’s investors, transactions and relationships in Altss.